2015
DOI: 10.1089/biores.2015.0024
|View full text |Cite
|
Sign up to set email alerts
|

A Scalable Perfusion Culture System with Miniature Peristaltic Pumps for Live-Cell Imaging Assays with Provision for Microfabricated Scaffolds

Abstract: We present a perfusion culture system with miniature bioreactors and peristaltic pumps. The bioreactors are designed for perfusion, live-cell imaging studies, easy incorporation of microfabricated scaffolds, and convenience of operation in standard cell culture techniques. By combining with miniature peristaltic pumps—one for each bioreactor to avoid cross-contamination and to maintain desired flow rate in each—we have made a culture system that facilitates perfusion culture inside standard incubators. This sc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 21 publications
0
14
0
Order By: Relevance
“…Such responses may present the opportunity to utilize these materials within devices in which cell/polymer interaction is confined to leachates within the culture medium. Pertinent to this are bespoke perfusion systems and microfluidic devices that are currently being utilized for the examination and recreation of musculoskeletal and neurological cellular physiological processes in vitro . The homogeneity of cytochrome P450 enzymatic activity across SL, LS, and PolyJet AM processes may also afford the opportunity to produce 3D‐printed fluidic devices that contain multiple cell types ( Table 2 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Such responses may present the opportunity to utilize these materials within devices in which cell/polymer interaction is confined to leachates within the culture medium. Pertinent to this are bespoke perfusion systems and microfluidic devices that are currently being utilized for the examination and recreation of musculoskeletal and neurological cellular physiological processes in vitro . The homogeneity of cytochrome P450 enzymatic activity across SL, LS, and PolyJet AM processes may also afford the opportunity to produce 3D‐printed fluidic devices that contain multiple cell types ( Table 2 ).…”
Section: Discussionmentioning
confidence: 99%
“…The possibility of 3D printing (also known as additive manufacturing (AM)) bespoke biologically receptive parts, has driven the increasing application of AM technologies in biological systems. Techniques such as fused deposition modeling (FDM), photopolymerization processes such as stereolithography (SL) and PolyJet printing, in addition to powder‐based particle consolidation laser sintering (LS) technology have all previously been utilized to provide devices/scaffolds for bioengineering . However, the numerous advantages of AM, including design freedom and rapid production without molds or tooling, are currently offset by a lack of fully characterized biocompatible materials …”
Section: Introductionmentioning
confidence: 99%
“…This may hold specific relevance within flow reactor applications of 3D printing, where it is of paramount importance to understand the effects of polymer chemical leachate on cellular behaviour, with many parts designed where polymer interaction is often confined to perfused medium, such as live-cell imaging systems. 2 Differential myotube phenotypes were observed in cells cultured on 3D printed polymers, with reductions in width documented in PLA, PET and PC conditions (Fig. 5A).…”
Section: Discussionmentioning
confidence: 90%
“…Therefore, as the volume of the bioreactors increase the need for sensory input also increases, as they are prone to the development of dead-spots, which are regions with suboptimal gas and media perfusion. 16 Examples of critical quality attributes (CQAs) that would benefit from sensors and enhance bioreactor performance include: small molecules and ions (pH, oxygen, and carbon dioxide), metabolites (glucose, lactate, and ammonia), and large macromolecules (enzymes, growth factors, and cytokines). [17][18][19] B.…”
Section: A Emerging Cell and Gene Therapy Manufacturing Paradigmsmentioning
confidence: 99%